8-89953701-A-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_002485.5(NBN):c.1398-10T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000333 in 1,532,342 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000046 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000032 ( 0 hom. )
Consequence
NBN
NM_002485.5 intron
NM_002485.5 intron
Scores
2
Splicing: ADA: 0.04734
2
Clinical Significance
Conservation
PhyloP100: 1.25
Genes affected
NBN (HGNC:7652): (nibrin) Mutations in this gene are associated with Nijmegen breakage syndrome, an autosomal recessive chromosomal instability syndrome characterized by microcephaly, growth retardation, immunodeficiency, and cancer predisposition. The encoded protein is a member of the MRE11/RAD50 double-strand break repair complex which consists of 5 proteins. This gene product is thought to be involved in DNA double-strand break repair and DNA damage-induced checkpoint activation. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 8-89953701-A-T is Benign according to our data. Variant chr8-89953701-A-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 234385.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=4}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NBN | NM_002485.5 | c.1398-10T>A | intron_variant | ENST00000265433.8 | NP_002476.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NBN | ENST00000265433.8 | c.1398-10T>A | intron_variant | 1 | NM_002485.5 | ENSP00000265433.4 |
Frequencies
GnomAD3 genomes AF: 0.0000463 AC: 7AN: 151250Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
7
AN:
151250
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000445 AC: 9AN: 202214Hom.: 0 AF XY: 0.0000182 AC XY: 2AN XY: 109778
GnomAD3 exomes
AF:
AC:
9
AN:
202214
Hom.:
AF XY:
AC XY:
2
AN XY:
109778
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000319 AC: 44AN: 1380974Hom.: 0 Cov.: 30 AF XY: 0.0000349 AC XY: 24AN XY: 687700
GnomAD4 exome
AF:
AC:
44
AN:
1380974
Hom.:
Cov.:
30
AF XY:
AC XY:
24
AN XY:
687700
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000462 AC: 7AN: 151368Hom.: 0 Cov.: 32 AF XY: 0.0000405 AC XY: 3AN XY: 73986
GnomAD4 genome
AF:
AC:
7
AN:
151368
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
73986
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Microcephaly, normal intelligence and immunodeficiency Uncertain:1Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | May 04, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Nov 07, 2021 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 18, 2024 | Variant summary: NBN c.1398-10T>A alters a non-conserved nucleotide located at a position not widely known to affect splicing. Several computational tools predict a significant impact on normal splicing: One predict the variant no significant impact on splicing. Two predict the variant weakens a 3' acceptor site. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 3.3e-05 in 1525986 control chromosomes, predominantly at a frequency of 0.00019 within the African or African-American subpopulation in the gnomAD database. This frequency is not higher than the estimated maximum for a pathogenic variant in NBN causing Nijmegen Breakage Syndrome (0.0025), allowing no conclusion about variant significance. c.1398-10T>A has been reported in the literature in individuals affected with breast cancer and other tumor phenotypes (e.g. van der Merwe_2022, Pearlman_2021). These report(s) do not provide unequivocal conclusions about association of the variant with Nijmegen Breakage Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 36568162, 34250417). ClinVar contains an entry for this variant (Variation ID: 234385). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 17, 2021 | Reported as a confirmed somatic variant in prostate and pancreatic cancer (Kumar 2016, McPherson 2020); In silico analysis supports a deleterious effect on splicing; This variant is associated with the following publications: (PMID: 26928463, 33339169) - |
Malignant tumor of breast Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The NBN c.1398-10T>A variant was identified in the literature as a somatic variant in pancreatic cancer (Kumar 2016). The variant was also identified in dbSNP (ID: rs539960851) as “With Uncertain significance allele”, ClinVar and Clinvitae (as uncertain significance by GeneDx and likely benign by Invitae), and Cosmic (4x in prostate cancer and 1x in pancreatic cancer). The variant was not identified in LOVD 3.0, and Zhejiang Colon Cancer Database. The variant was identified in control databases in 9 of 198294 chromosomes at a frequency of 0.000045 (Genome Aggregation Database Feb 27, 2017). Breakdown of the observations by population include African in 6 of 12338 chromosomes (freq: 0.000486), and European (Non-Finnish) in 3 of 87742 chromosomes (freq: 0.000034), while the variant was not observed in the Other, Latino, Ashkenazi Jewish, East Asian, European (Finnish), and South Asian populations. The variant occurs outside of the splicing consensus sequence and 2 of 5 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) predict a greater than 10% difference in splicing; this is not very predictive of pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
Hereditary breast ovarian cancer syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | National Health Laboratory Service, Universitas Academic Hospital and University of the Free State | Apr 19, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at